Document is current

Article History

Received: 17 July 2023

Accepted: 20 December 2023

First Online: 13 January 2024

Declarations

:

: The study protocols have been reviewed and approved in the three cities. The clinical trial of Barcelona received the approval of Research Ethics Committee (REC) at UVic-UCC with the registration number 2014/2022 on 28/06/2022 and Primary Health Care Research Institute of Catalonia with the registration number 22/170-P on 02/08/2022. Moreover, the consortium obtained the approval of the Helsinki University Hospital Ethics Committee (No HUS/119/2022). They also received approval from Social Services and Health Care of the City of Helsinki on 13.06.2022. Finally, the protocol in Prague was approved by the Ethics Committee of the Faculty of Humanities, Charles University on June 28, 2022.Throughout the RECETAS project, ethics review and approval will be obtained for all aspects of the study by the relevant local ethics committees before any work is conducted. Informed consent will be obtained from all study participants before enrollment in the study. (Appendix , , ). Human subjects’ data generated throughout this project will be anonymized and safeguards will be in place to ensure protection of human subjects’ data. We will conduct a full ethics review of the project in partnership with the European Commission along the project.

: Not applicable.

: The authors declare no competing interests.